Lista de obras - David Keeling - Dominio Público Uruguay

A case of fatal pulmonary embolism raising questions about the dosing regimen for dalteparin in the very obese.

artículo científico publicado en 2008

A family with type 2M VWD with normal VWF:RCo but reduced VWF:CB and a M1761K mutation in the A3 domain.

artículo científico publicado en 2011

A practical guideline for the haematological management of major haemorrhage

artículo científico publicado en 2015

A prospective registry of European haemophilia B patients receiving nonacog alfa, recombinant human factor IX, for usual use.

artículo científico publicado en 2011

A raised beta 2-glycoprotein I level does not prolong the DRVVT

artículo científico publicado en 1992

A simplified statistical method for local INR using linear regression

artículo científico publicado el 1 de diciembre de 1997

A single dose of Low-molecular-weight Heparin (LMWH) invalidates the use of D-dimer as part of a Deep Vein Thrombosis (DVT) diagnostic algorithm.

artículo científico publicado en 2016

Achievement of immune tolerance in a patient with haemophilia B and inhibitory antibodies, complicated by an anaphylactoid reaction.

artículo científico publicado en 2007

Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.

artículo científico publicado en 2006

Activated prothrombin complex concentrate for the prevention of dabigatran-associated bleeding

artículo científico publicado en 2014

Ala-10 mutations in the factor IX propeptide and haemorrhage in a patient treated with warfarin

artículo científico publicado en 2000

An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease

artículo científico publicado en 2006

Anti-DNA antibodies in the primary antiphospholipid syndrome (PAPS)

artículo científico publicado en 1993

Audit of anticoagulation after embolectomy for acute ischaemia.

scientific article published on 25 June 2009

Changing patterns of bleeding in patients with severe haemophilia A.

artículo científico publicado en 2009

Combined oral contraceptives and the risk of myocardial infarction.

artículo científico publicado en 2003

Comparison of a point of care device against current laboratory methodology using citrated and EDTA samples for the determination of D-dimers in the exclusion of proximal deep vein thrombosis.

artículo científico publicado en 2010

Comparison of an immuno-turbidometric method (STalia D-DI) with an established enzyme linked fluorescent assay (VIDAS) D-dimer for the exclusion of venous thromboembolism.

artículo científico publicado en 2008

Controversies in venous thromboembolism--2015.

artículo científico

Cryoprecipitate prepared from plasma virally inactivated by the solvent detergent method

scientific article published on 01 January 1997

D-dimer for the exclusion of venous thromboembolism: comparison of a new automated latex particle immunoassay (MDA D-dimer) with an established enzyme-linked fluorescent assay (VIDAS D-dimer)

scientific article published on 01 October 1999

D-dimer test for excluding the diagnosis of pulmonary embolism

artículo científico publicado en 2016

Diagnosis and management of heritable thrombophilias.

artículo científico publicado en 2014

Diagnostic importance of the two-stage factor VIII:C assay demonstrated by a case of mild haemophilia associated with His1954-->Leu substitution in the factor VIII A3 domain.

artículo científico publicado en 1999

Duration of anticoagulation: decision making based on absolute risk.

artículo científico publicado en 2005

Effect of age on factor IX levels in symptomatic carriers of Haemophila B Leyden.

artículo científico publicado en 2014

Efficacy of warfarin reversal in orthopedic trauma surgery patients.

artículo científico publicado en 2007

Evaluation of the von Willebrand factor antigen (vWF-Ag) assay using an immuno-turbidimetric method (STA Liatest vWF) automated on the MDA 180 coagulometer.

artículo científico publicado en 2000

Factor V Leiden haplotypes in two homozygotes of Asian origin.

artículo científico publicado en 1998

Factor VIII assays in haemophilia a patients treated with ReFacto.

artículo científico publicado en 2003

Factor X deficiency associated with compound heterozygosity involving a novel missense mutation at codon 38 from Val (GTC) to Leu (CTC) in exon 2.

artículo científico publicado en 2015

Fatal thromboembolism in acute promyelocytic leukaemia treated with a combination of all-trans retinoic acid and aprotonin.

artículo científico publicado en 1996

Genetic predisposition to bleeding during oral anticoagulant therapy: evidence for common founder mutations (FIXVal-10 and FIXThr-10) and an independent CpG hotspot mutation (FIXThr-10)

artículo científico publicado en 2001

Guideline on aspects of cancer-related venous thrombosis

artículo científico publicado en 2015

Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. A United Kingdom Haemophilia Center Doctors' Organisation (UKHCDO) guideline approved by the British Committee for Standards in

artículo científico publicado en 2008

Guidelines on oral anticoagulation with warfarin – fourth edition ⬇️

artículo científico publicado el 14 de junio de 2011

Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: second edition.

artículo científico publicado en 2012

Guidelines on the investigation and management of venous thrombosis at unusual sites

artículo científico publicado en 2012

Haematological manifestations of systemic lupus erythematosus.

artículo científico publicado en 1993

Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation?

artículo científico publicado en 1988

Have You Been HIT?

artículo científico publicado en 2011

Heparin pretreatment does not alter heparin requirements during cardiopulmonary bypass.

artículo científico publicado en 2001

Hormone replacement therapy, thrombosis and thrombophilia

artículo científico publicado en 2005

Idarucizumab for dabigatran overdose in a child

artículo científico publicado en 2016

Inherited coagulation disorders

artículo científico publicado en 2001

International Normalized Ratio (INR) determination using calibrated reference plasmas.

artículo científico publicado en 1997

International Normalized Ratio in patients not on vitamin K antagonists.

artículo científico publicado en 2006

Is there a benefit in computed tomography screening for cancer in patients with unprovoked proximal deep venous thrombosis? A cohort study in the Oxford University Hospitals NHS Trust

artículo científico publicado en 2015

Management of bleeding in patients taking FXa and FIIa inhibitors.

artículo científico publicado en 2012

Management of muscle haematomas in patients with severe haemophilia in an evidence-poor world.

artículo científico

Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization.

artículo científico publicado en 2004

Managing antiplatelet and anticoagulant drugs in patients undergoing elective ophthalmic surgery

artículo científico publicado en 2014

Managing antiplatelet and anticoagulant drugs in patients undergoing elective ophthalmic surgery. Authors' response

artículo científico publicado en 2014

Multiple transient ischaemic attacks and a mild thrombotic stroke in a HIV-positive patient with anticardiolipin antibodies.

artículo científico publicado en 1990

Myocardial infarction following recombinant activated factor VII in a patient with type 2A von Willebrand disease.

artículo científico publicado en 2004

Normal d-dimer levels do not exclude the diagnosis of cerebral venous sinus thrombosis

artículo científico publicado en 2002

Optimal loading dose for the initiation of warfarin: a systematic review

artículo científico publicado en 2010

Optimal loading dose of warfarin for the initiation of oral anticoagulation

artículo científico publicado en 2012

Patient self-testing and self-management of oral anticoagulation with vitamin K antagonists: guidance from the British Committee for Standards in Haematology

artículo científico publicado en 2014

Peri-operative management of anticoagulation and antiplatelet therapy

artículo científico publicado en 2016

Perioperative replacement therapy in haemophilia B: An appeal to “B” more precise

scientific article published on 29 April 2018

Plasma exchange as a source of protein C for acute-onset protein C pathway failure

artículo científico publicado en 2003

Population pharmacokinetics of factor IX in hemophilia B patients undergoing surgery

artículo científico publicado en 2018

Predicting the future: it's not a SNP.

artículo científico publicado en 2008

Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies.

artículo científico publicado en 1998

Pulmonary embolus in Glanzmann's thrombasthenia treated with warfarin

artículo científico publicado en 2008

Rebuttal--a prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation

artículo científico publicado en 2000

Reducing the need for diagnostic imaging in suspected cases of deep vein thrombosis

artículo científico publicado en 2018

Relation between acute hypoxia and activation of coagulation in human beings

scientific article published in The Lancet

Rituximab and immune tolerance in severe hemophilia A: a consecutive national cohort.

artículo científico publicado en 2009

Role of beta 2-glycoprotein I and anti-phospholipid antibodies in activation of protein C in vitro

artículo científico publicado en 1993

Safety indicators for inpatient and outpatient oral anticoagulant care: [corrected] Recommendations from the British Committee for Standards in Haematology and National Patient Safety Agency

scientific article published on 20 November 2006

Sagittal sinus thrombosis in a teenager: homocystinuria associated with reversible antithrombin deficiency.

artículo científico publicado en 2002

Should we screen for factor V Leiden? ⬇️

artículo científico publicado el 1 de enero de 1998

Some 'antiphospholipid antibodies' bind to beta 2-glycoprotein I in the absence of phospholipid

scientific article published on 01 November 1992

Stockings to prevent post-thrombotic syndrome-where are we now?

artículo científico publicado en 2018

The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran.

scientific article published on 22 February 2013

The aspirin story - from willow to wonder drug.

artículo científico publicado en 2017

The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.

artículo científico publicado en 2006

The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology

artículo científico publicado en 2014

The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization.

artículo científico publicado en 2004

The fibrinolytic response to venous occlusion and the natural anticoagulants in patients with antiphospholipid antibodies both with and without systemic lupus erythematosus

scientific article published on 01 March 1991

The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99.

artículo científico publicado en 2004

The management of heparin-induced thrombocytopenia

scientific article published on 04 September 2006

The management of heparin-induced thrombocytopenia.

artículo científico publicado en 2006

The prevalence of the cysteine1584 variant of von Willebrand factor is increased in type 1 von Willebrand disease: co-segregation with increased susceptibility to ADAMTS13 proteolysis but not clinical phenotype.

artículo científico publicado en 2005

The use of age-dependent D-dimer cut-off values to exclude deep vein thrombosis. Reply to "Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded". Haematologica 2012;9

artículo científico publicado en 2012

The use of artificial neural network analysis can improve the risk-stratification of patients presenting with suspected deep vein thrombosis

artículo científico publicado en 2019

The use of enhanced half-life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO.

artículo científico publicado en 2016

The use of rituximab in two children with allo-antibodies towards factor VIII.

artículo científico publicado en 2006

Treating alcohol dependence. One glass of wine is usually 1.5 units.

artículo científico publicado en 1997

Treatment related factors and inhibitor development in children with severe haemophilia A.

artículo científico publicado en 2010

Treponemal infection coexisting with systemic lupus erythematosus

scientific article published on 01 May 1992

Unexpected haemophilia despite pre-natal testing - a combined haemophilia A and haemophilia B family.

artículo científico publicado en 2017

Universal or selected screening for thrombophilia.

artículo científico publicado en 2006

Variation in inhibitor reactivity in acquired haemophilia A with different concentrates.

artículo científico publicado en 2000

Venous thromboembolism: risk of recurrence and long-term anticoagulation

artículo científico publicado en 2015

Von Willebrand disease, angiodysplasia and atorvastatin.

artículo científico publicado en 2009

von Willebrand disease and extra-intestinal angiodysplasia.

artículo científico publicado en 2017

Lista de obras de David Keeling

A case of fatal pulmonary embolism raising questions about the dosing regimen for dalteparin in the very obese.

A family with type 2M VWD with normal VWF:RCo but reduced VWF:CB and a M1761K mutation in the A3 domain.

A practical guideline for the haematological management of major haemorrhage

A prospective registry of European haemophilia B patients receiving nonacog alfa, recombinant human factor IX, for usual use.

A raised beta 2-glycoprotein I level does not prolong the DRVVT

A simplified statistical method for local INR using linear regression

A single dose of Low-molecular-weight Heparin (LMWH) invalidates the use of D-dimer as part of a Deep Vein Thrombosis (DVT) diagnostic algorithm.

Achievement of immune tolerance in a patient with haemophilia B and inhibitory antibodies, complicated by an anaphylactoid reaction.

Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.

Activated prothrombin complex concentrate for the prevention of dabigatran-associated bleeding

Ala-10 mutations in the factor IX propeptide and haemorrhage in a patient treated with warfarin

An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease

Anti-DNA antibodies in the primary antiphospholipid syndrome (PAPS)

Audit of anticoagulation after embolectomy for acute ischaemia.

Changing patterns of bleeding in patients with severe haemophilia A.

Combined oral contraceptives and the risk of myocardial infarction.

Comparison of a point of care device against current laboratory methodology using citrated and EDTA samples for the determination of D-dimers in the exclusion of proximal deep vein thrombosis.

Comparison of an immuno-turbidometric method (STalia D-DI) with an established enzyme linked fluorescent assay (VIDAS) D-dimer for the exclusion of venous thromboembolism.

Controversies in venous thromboembolism--2015.

Cryoprecipitate prepared from plasma virally inactivated by the solvent detergent method

D-dimer for the exclusion of venous thromboembolism: comparison of a new automated latex particle immunoassay (MDA D-dimer) with an established enzyme-linked fluorescent assay (VIDAS D-dimer)

D-dimer test for excluding the diagnosis of pulmonary embolism

Diagnosis and management of heritable thrombophilias.

Diagnostic importance of the two-stage factor VIII:C assay demonstrated by a case of mild haemophilia associated with His1954-->Leu substitution in the factor VIII A3 domain.

Duration of anticoagulation: decision making based on absolute risk.

Effect of age on factor IX levels in symptomatic carriers of Haemophila B Leyden.

Efficacy of warfarin reversal in orthopedic trauma surgery patients.

Evaluation of the von Willebrand factor antigen (vWF-Ag) assay using an immuno-turbidimetric method (STA Liatest vWF) automated on the MDA 180 coagulometer.

Factor V Leiden haplotypes in two homozygotes of Asian origin.

Factor VIII assays in haemophilia a patients treated with ReFacto.

Factor X deficiency associated with compound heterozygosity involving a novel missense mutation at codon 38 from Val (GTC) to Leu (CTC) in exon 2.

Fatal thromboembolism in acute promyelocytic leukaemia treated with a combination of all-trans retinoic acid and aprotonin.

Genetic predisposition to bleeding during oral anticoagulant therapy: evidence for common founder mutations (FIXVal-10 and FIXThr-10) and an independent CpG hotspot mutation (FIXThr-10)

Guideline on aspects of cancer-related venous thrombosis

Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. A United Kingdom Haemophilia Center Doctors' Organisation (UKHCDO) guideline approved by the British Committee for Standards in

Guidelines on oral anticoagulation with warfarin – fourth edition ⬇️

Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: second edition.

Guidelines on the investigation and management of venous thrombosis at unusual sites

Haematological manifestations of systemic lupus erythematosus.

Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation?

Have You Been HIT?

Heparin pretreatment does not alter heparin requirements during cardiopulmonary bypass.

Hormone replacement therapy, thrombosis and thrombophilia

Idarucizumab for dabigatran overdose in a child

Inherited coagulation disorders

International Normalized Ratio (INR) determination using calibrated reference plasmas.

International Normalized Ratio in patients not on vitamin K antagonists.

Is there a benefit in computed tomography screening for cancer in patients with unprovoked proximal deep venous thrombosis? A cohort study in the Oxford University Hospitals NHS Trust

Management of bleeding in patients taking FXa and FIIa inhibitors.

Management of muscle haematomas in patients with severe haemophilia in an evidence-poor world.

Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization.

Managing antiplatelet and anticoagulant drugs in patients undergoing elective ophthalmic surgery

Managing antiplatelet and anticoagulant drugs in patients undergoing elective ophthalmic surgery. Authors' response

Multiple transient ischaemic attacks and a mild thrombotic stroke in a HIV-positive patient with anticardiolipin antibodies.

Myocardial infarction following recombinant activated factor VII in a patient with type 2A von Willebrand disease.

Normal d-dimer levels do not exclude the diagnosis of cerebral venous sinus thrombosis

Optimal loading dose for the initiation of warfarin: a systematic review

Optimal loading dose of warfarin for the initiation of oral anticoagulation

Patient self-testing and self-management of oral anticoagulation with vitamin K antagonists: guidance from the British Committee for Standards in Haematology

Peri-operative management of anticoagulation and antiplatelet therapy

Perioperative replacement therapy in haemophilia B: An appeal to “B” more precise

Plasma exchange as a source of protein C for acute-onset protein C pathway failure

Population pharmacokinetics of factor IX in hemophilia B patients undergoing surgery

Predicting the future: it's not a SNP.

Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies.

Pulmonary embolus in Glanzmann's thrombasthenia treated with warfarin

Rebuttal--a prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation

Reducing the need for diagnostic imaging in suspected cases of deep vein thrombosis

Relation between acute hypoxia and activation of coagulation in human beings

Rituximab and immune tolerance in severe hemophilia A: a consecutive national cohort.

Role of beta 2-glycoprotein I and anti-phospholipid antibodies in activation of protein C in vitro

Safety indicators for inpatient and outpatient oral anticoagulant care: [corrected] Recommendations from the British Committee for Standards in Haematology and National Patient Safety Agency

Sagittal sinus thrombosis in a teenager: homocystinuria associated with reversible antithrombin deficiency.

Should we screen for factor V Leiden? ⬇️

Some 'antiphospholipid antibodies' bind to beta 2-glycoprotein I in the absence of phospholipid

Stockings to prevent post-thrombotic syndrome-where are we now?

The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran.

The aspirin story - from willow to wonder drug.

The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.